Here’s What Analysts Think About Thermo Fisher Scientific (TMO) Post Earnings

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best strong buy healthcare stocks to invest in. Thermo Fisher Scientific Inc. (NYSE:TMO) reported its fiscal Q4 and full-year 2025 results on January 29, announcing that fiscal Q4 revenue grew 7% to $12.21 billion. GAAP diluted earnings per share for the quarter grew 9% to $5.21, while adjusted EPS rose 8% to $6.57. In addition, full year revenue underwent a 4% growth to $44.56 billion, with GAAP diluted earnings per share rising 7% to $17.74, and adju ...